Xiaoqiu Yuan
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Molecular residual disease-based novel modality of postoperative management for non-small-cell lung cancer (REMODEL): Protocol for a prospective multicenter study.
Journal: Journal of translational internal medicine
Published: July 02, 2026
Protocol for Chinese lung cancer evolution and microenvironment tracking under therapy study.
Journal: Journal of translational internal medicine
Published: December 24, 2025
Hallmarks of lung cancer driven by inhalable particulate matter: From cell-intrinsic oncogenic traits to microenvironment remodeling.
Journal: Innovation (Cambridge (Mass.))
Published: August 14, 2025
Next-Generation Sequencing vs. Clinical-Pathological Assessment in Diagnosis of Multiple Lung Cancers: A Systematic Review and Meta-Analysis.
Journal: Thoracic cancer
Published: December 24, 2024
Optimizing the NGS-based discrimination of multiple lung cancers from the perspective of evolution.
Journal: NPJ precision oncology
Published: April 01, 2024
Development of new techniques and clinical applications of liquid biopsy in lung cancer management.
Journal: Science bulletin
Published: September 25, 2023
Towards the molecular era of discriminating multiple lung cancers.
Journal: EBioMedicine
Published: October 22, 2022
Case Report: A Novel CACNA1A Mutation Caused Flunarizine-Responsive Type 2 Episodic Ataxia and Hemiplegic Migraine With Abnormal MRI of Cerebral White Matter.
Journal: Frontiers in neurology
Published: March 19, 2022
Efficacy and Safety of Tacrolimus Therapy for a Single Chinese Cohort With Very-Late-Onset Myasthenia Gravis.
Journal: Frontiers in neurology
Published: December 26, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026